Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 118.9B | 114.2B | 112.2B | 103.4B |
Cost of revenue | 81.1B | 79.1B | 73.0B | 68.1B |
Gross profit | 37.8B | 35.1B | 39.2B | 35.3B |
Operating expense | ||||
Research & development | 11.1B | 11.2B | 10.8B | 10.6B |
Selling general and admin | 12.6B | 13.3B | 12.1B | 11.4B |
Other operating expenses | — | — | — | — |
Operating income | 14.2B | 10.7B | 16.3B | 13.3B |
Non operating interest income | ||||
Income | 823.8M | 888.6M | 924.0M | 893.4M |
Expense | 510.5M | 450.5M | 403.2M | 353.9M |
Other income expense | — | — | — | — |
Pretax income | 15.7B | 9.8B | 17.7B | 15.0B |
Tax provision | 3.6B | 2.5B | 3.5B | 3.1B |
Net income | 12.0B | 7.3B | 14.1B | 12.0B |
Basic EPS | 3.9 | — | 4.8 | 3.8 |
Diluted EPS | 3.9 | — | 4.7 | 3.8 |
Basic average shares | 2.6B | — | 2.6B | 2.6B |
Diluted average shares | 2.6B | — | 2.6B | 2.6B |
EBITDA | 23.1B | 17.0B | 24.2B | 21.8B |
Net income from continuing op. | 15.7B | 9.8B | 17.7B | 15.0B |
Minority interests | -1.8B | -145.4M | -1.8B | -2.0B |
Preferred stock dividends | 0 | 0 | 0 | 0 |